MedTrace Logo

Brief Title- Virtual Reality Glasses in Gynecologic Cancer

NCT06760689 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2025-01-07

No results posted yet for this study

Summary

It was planned to determine the effect of virtual reality glasses used in female patients diagnosed with gynecological cancer and receiving chemotherapy on treatment compliance and anxiety level. The study has a single-center, randomized controlled experimental design.

Conditions

Interventions

DEVICE

virtual reality glasses

One of the videos chosen by the patient will be opened in the virtual reality glasses and will be played for 20 minutes.

OTHER

scale

The patient received standard nursing care. Scales were filled in after the course.

Sponsors & Collaborators

  • Çankırı Karatekin University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-01
Primary Completion
2025-03-31
Completion
2025-07-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06760689 on ClinicalTrials.gov